Evidence map›Paper›PMID 20535528›Full record

ArticleJournal of neuro-oncology2011

Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme.

Katarzyna Kosla, Elzbieta Pluciennik, Agata Kurzyk, Dorota Jesionek-Kupnicka, Radzislaw Kordek, Piotr Potemski, Andrzej K Bednarek

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuro-oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. WWOX and metabolic regulation in normal and pathological conditions.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  4. Review
  5. TheExperimental biology and medicine (Maywood, N.J.) · 2020
    Review
  6. TheFrontiers in cellular neuroscience · 2019
    Article
  7. Frontiers in oncology · 2018
    Review
  8. WWOX: a fragile tumor suppressor.Experimental biology and medicine (Maywood, N.J.) · 2015
    Review
  9. Alteration of WWOX in human cancer: a clinical view.Experimental biology and medicine (Maywood, N.J.) · 2015
    Review
  10. Article
  11. Alternating expression levels ofOncology letters · 2014
    Article
  12. Article
  13. Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  14. Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.International journal of biological sciences · 2014
    Review
  15. Article
  16. Review
  17. Article
  18. WWOX expression in colorectal cancer--a real-time quantitative RT-PCR study.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Katarzyna KoslaDepartment of Molecular Cancerogenesis, Medical University of Lodz, Mazowiecka St 6/8, 92-215 Lodz, Poland. kkosla@csk.umed.lodz.pl
Elzbieta Pluciennik
Agata Kurzyk
Dorota Jesionek-Kupnicka
Radzislaw Kordek
Piotr Potemski
Andrzej K Bednarek
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme is the most common type of primary brain tumor in adults. WWOX is a tumor suppressor gene involved in carcinogenesis and cancer progression in many different neoplasms. Reduced WWOX expression is associated with more aggressive phenotype and poor patient outcome in several cancers. We investigated alternations of WWOX expression and its correlation with proliferation, apoptosis and signal trafficking in 67 glioblastoma multiforme specimens. Moreover, we examined the level of WWOX LOH and methylation status in WWOX promoter region. Our results suggest that loss of heterozygosity (relatively frequent in glioblastoma multiforme) along with promoter methylation may decrease the expression of this tumor suppressor gene. Our experiment revealed positive correlations between WWOX and Bcl2 and between WWOX and Ki67. We also confirmed that WWOX is positively correlated with ErbB4 signaling pathway in glioblastoma multiforme.

Indexed as

Cell ProliferationAdultAgedApoptosisBrain NeoplasmsErbB ReceptorsFemaleGene Expression Regulation, NeoplasticGlioblastomaHumansKi-67 AntigenLoss of HeterozygosityMaleMiddle AgedOxidoreductasesProto-Oncogene Proteins c-bcl-2ERBB4 protein, humanErbB ReceptorsKi-67 AntigenOxidoreductasesProto-Oncogene Proteins c-bcl-2Receptor, ErbB-4Tumor Suppressor ProteinsWW Domain-Containing OxidoreductaseWWOX protein, human

Identifiers

PMID20535528
PMCPMC2996532
OpenAlexW2040730218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.